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1 |  CASE REPORT
A 24- year- old Caucasian man presented with a several month 
history of muscle pain, fatigue and insidious onset of pitting 
edema to his lower extremities. His symptoms progressed 
to include bilateral arm swelling, muscle pain to the thenar 
eminence of both hands, and paresthesias to his hands. He 
did not have a rash, joint pain, Raynaud phenomenon, oral 
ulcers, fever, hardening of the skin or weight loss, and he 
denied any cardiac, respiratory, genitourinary, or gastroin-
testinal symptoms. Prior to symptom onset, he had traveled 
to South America and reported possible ingestion of under-
cooked meat as well as swimming in a river and lake. He 
had frequent visits to the Northeastern United States and 
had recently spent an extended period of time outdoors in 
Rhode Island. Medical, surgical, and family histories were 
unremarkable, and he was not taking any medications. He 
had a history of mild alcohol intake, no history of smoking, 
and some marijuana use. On examination, his vital signs re-
vealed a blood pressure of 104/57 mm Hg, pulse of 56 bpm, 
and normal temperature. He had no significant findings on 
head, neck, cardiovascular, respiratory, or abdominal exam. 
He had no cervical, axillary, or inguinal lymphadenopathy. 
He had significant pitting edema on his feet and legs extend-
ing up to his knees as well as non- pitting edema on the dor-
sum of both hands. Although there was edema, the skin was 
soft without any significant hardening and was without any 
overlying erythema. There were no signs of skin dimpling 
or grooves. His neurological examination revealed normal 
strength.
His initial laboratory work was significant for a mild 
eosinophilia of 700 with a normal white blood cell count, 
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hemoglobin, and platelets. He had normal calcium, creat-
inine, and electrolyte levels. His alanine aminotransferase 
was slightly elevated and total protein slightly low, but he 
had normal albumin and bilirubin. His thyroid- stimulating 
hormone was slightly increased, but his free T4 and total 
T3 were normal. His urinalysis was normal. He had a nor-
mal level of creatine phosphokinase, sedimentation rate, and 
C- reactive protein. Further workup revealed a positive anti- 
nuclear antibody with a titer of 1:160 with a speckled pattern. 
His extractable nuclear antigen panel was negative, including 
Scl- 70. His ANCA, myeloperoxidase and proteinase- 3 serum 
studies were also negative. His ACE level and complement 
levels were normal. Infectious workup revealed negative 
stool studies for culture, ova, and parasites. Antibodies for 
HIV, CMV, and Trichinella were negative. Serum for histo-
plasmosis, cryptosporidium, coccidiomycosis, and interferon 
gamma release assay were negative. A blood smear for par-
asites was negative. An ELISA IgG/IgM test for Lyme dis-
ease was positive with subsequent testing with Western blot 
strongly positive for IgG (eight out of ten bands positive) and 
also positive for IgM (two out of three bands positive).
The patient had extensive imaging done with a normal CT 
scan of his neck, chest, abdomen, and pelvis. An echocardio-
gram was also normal. Due to a previous negative workup 
along with persistent pain and swelling, an MRI of his right 
lower extremity was performed (see Figure 1). Imaging 
demonstrated extensive circumferential edema with enhance-
ment of the superficial soft tissues, superficial fascia, and, 
to a lesser extent, deep fascia of the lower leg. Taking into 
account the mild peripheral eosinophilia and the imaging 
findings, a diagnosis of eosinophilic fasciitis was considered. 
To complete the workup, a biopsy of the fascia, muscle, and 
adipose tissue of the left calf was taken (see Figure 2). The 
biopsy did not include the dermis. Surprisingly, there was 
no evidence of eosinophilic fasciitis. Instead, the specimen 
illustrated a striking granulomatous fasciitis and vasculitis. 
The fascia showed exuberant granulomatous inflammation 
(Figure 2A) with an inflammatory infiltrate that was made 
up predominately of histiocytes and CD3- positive T cells 
with very rare eosinophils (Figure 2B). The granulomatous 
inflammation centered primarily on small- to medium- sized 
blood vessels and was non- necrotizing. While the vessels did 
not display overt fibrinoid necrosis, they did appear damaged 
with loss of endothelial cells confirmed with CD31 immunos-
taining. The inflammatory infiltrate was seen extending into 
adipose tissue and particularly around blood vessels within 
the fat. The adjacent skeletal muscle also showed perivascu-
lar inflammation and vasculitis in both the perimysial and en-
domysial compartments. There was no endomysial fibrosis, 
fatty infiltration, or inflammation surrounding muscle fibers. 
AFB (acid- fast bacteria) and Wade- Fite stain were negative 
for mycobacterial organisms. GMS (Grocott- Gomori’s meth-
enamine silver) stain was negative for fungal organisms. Due 
to the positive Western blot for Lyme, a Warthin- Starry sil-
ver nitrate stain was performed to evaluate for spirochetes; 
however, no definitive organisms were seen. A Borrelia PCR 
F I G U R E  1  Initial magnetic resonance imaging of the right lower extremity (axial plane from left to right with TR/TE times [in msec]: T1 
[564/12], T2 fat- suppressed [4517/70], T1 precontrast fat- suppressed [599/12], and T1 postcontrast fat- suppressed [599/12]) demonstrates extensive 
circumferential edema and enhancement of the superficial soft tissues and superficial fascia (asterisks) and, to a lesser extent, the deep fascia 
(arrows)
F I G U R E  2  A and B, The fascia shows 
exuberant granulomatous inflammation. 
The inflammatory infiltrate is composed of 
enumerable histiocytes, many lymphocytes 
(predominantly CD3 positive T cells), rare 
plasma cells, and very rare eosinophils 
(hematoxylin- eosin, magnification x40 [A] 
x100[B])
(A) (B)
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analysis of the tissue was performed as well, but no DNA was 
detected.
The patient was given a diagnosis of granulomatous fas-
ciitis along with a diagnosis of Lyme disease. He was first 
treated with doxycycline for 42 days straight due to initial 
Lyme serology being positive. The calf biopsy revealing fas-
ciitis was not performed until the patient was 3 weeks into 
the doxycycline course. Once fasciitis was diagnosed, he was 
started on a prednisone taper starting at 1 mg/kg/day for a 
week with taper by 10 mg every 2 weeks. After 2 months of 
treatment with prednisone, the patient had near resolution of 
symptoms. A repeat MRI was performed 82 days after the 
initial MRI with the previously seen changes consistent with 
fasciitis nearly completely resolved with only a thin sliver of 
edema over the superficial fascia. On re- evaluation of the pa-
tient, he reported skin changes to his left upper arm at 20 mg 
of prednisone per day and skin changes to his left forearm at 
7.5 mg per day. Examination of the upper arm revealed an 
atrophic patch with some overlying erythema and examina-
tion of the forearm showed indurated, bound- down, tense skin 
with a slight groove and minimal overlying hyperpigmenta-
tion. The rest of the dermatological examination was within 
normal limits. Skin biopsy revealed marked septal thickening 
with sclerosis, sparse lymphoplasmacytic infiltrate along the 
dermal subcutaneous junction, and swollen, homogenized 
collagen fibers with diminished spaces between the fibers 
(see Figure 3). The clinical examination along with pathol-
ogy revealing dermal and subcutaneous sclerosis was consis-
tent with a diagnosis morphea profunda. Lyme serology was 
repeated, but Western blot for IgG was negative. A sclero-
derma antibody panel was negative as well. He was started on 
methotrexate and a higher dose of prednisone.
2 |  DISCUSSION
Upon review of the literature, granulomatous fasciitis is rarely 
reported. In 1982, Lewkonia, et al1 described two cases with 
clinical and histological features of eosinophilic fasciitis, but 
also with histologic findings of granuloma formation in as-
sociation with prominent vasculitis. The first case described 
a 47- year- old man with myalgias, arthralgias, and edema 
with subcutaneous induration of the distal extremities, but 
no signs of cutaneous vasculitis. Laboratories revealed pe-
ripheral eosinophilia. Calf biopsy was consistent with granu-
lomatous vasculitis, thickened fascia with an eosinophilic 
infiltrate, and granuloma formation in the fascia. The patient 
was treated with a 20- mg prednisone taper with resolution 
of most symptoms by 1 month. The second case described a 
14- year- old girl with subcutaneous swelling and induration 
of both legs with subsequent development of upper extrem-
ity brawny edema and stiffness. She had mild peripheral eo-
sinophilia with calf biopsy revealing fascial thickening with 
lymphocytic infiltrate with scattered eosinophils and promi-
nent perivascular mononuclear infiltration with granuloma 
formation in the fascia, muscle, and dermis. She required 
prednisone 100 mg on alternate days with improvement in 
symptoms by 8 months.
Few cases of granulomatous fasciitis have been reported 
due to sarcoidosis, but muscle was also involved.2-5 The first 
known cases were reported in 1990, with accounts of two 
female patients with histopathological proven granuloma-
tous myositis associated with a fasciitis.2 Another reported 
case revealed fasciitis via FDG- PET in a patient with known 
pulmonary sarcoidosis who presented with bilateral calf and 
thigh stiffness; however, no biopsy was performed.4 The most 
recent case revealed changes suggestive of fasciitis via MRI 
of the abdomen, pelvis, and thighs in a patient with weight 
loss without swelling or skin changes. Biopsy of the thigh 
revealed fasciitis with non- caseating granulomas.5
Upon further literature review of granulomatous fasciitis, 
few other associated reports were found. Richard Prayson 
reviewed 2985 muscle biopsy specimens over a twelve- year 
time period and found only 12 cases (0.4%) with granuloma-
tous myositis. All cases exhibited non- necrotizing granulomas 
with infiltrates predominately made up of lymphocytes and 
plasma cells. Staining for acid- fast bacilli and methenamine 
silver was negative. Of the 12 cases, 6 were diagnosed with 
sarcoidosis, 2 with vasculitis, 2 not otherwise specified, and 
2 with insufficient information for diagnosis.6 Vaccination 
causing a histiocyte reaction should also be considered in 
the differential of granulomatous fasciitis. Vaccinations with 
F I G U R E  3  A and B, Sections show 
marked sclerosis with excessive collagen 
deposition in both mid- dermis (A) and 
deep dermis (B) (hematoxylin- eosin, 
magnification x100)
(A) (B)
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aluminum oxyhydroxide have been shown to cause a long- 
term persistence of alum- loaded macrophages at the site or 
prior intra- muscular injection, forming a histiocytic lesion 
called macrophagic myofasciitis. It can be differentiated from 
other types of fasciitis by a crystalline inclusion in the mac-
rophages and lack of granuloma formation.7 In veterinarian 
literature review, cases of granulomatous fasciitis have also 
been described in birds 8 (due to B procyonis), cats,9 and eels 
10 (due to novel Mycobacterium species).
Although suspected in our patient, but proven to be oth-
erwise, eosinophilic fasciitis can present in a similar fash-
ion as granulomatous fasciitis. Eosinophilic fasciitis (EF) 
is a rare disorder, first described by Shulman in 1974.11 It 
is characterized by limb or trunk erythema and edema with 
subsequent development of collagenous thickening of the 
subcutaneous fascia. Initial findings are a nonpitting edema 
that can progress to induration with puckering and a woody 
texture (peau d’orange).1,11 Unlike scleroderma, the skin of 
the hands and feet is generally spared and it is not associated 
with Raynaud phenomenon. Another typical finding is the 
groove sign (indentation along the course of the superficial 
veins upon elevation of the affected limb). The majority of 
patients with EF have a peripheral blood eosinophilia, which 
is transient and does not correlate with disease severity. About 
half will have an elevated sedimentation rate and C- reactive 
protein. It is also associated with hypergammaglobulinemia. 
Fascial inflammation can be suggested by MRI, FDG- PET/
CT, or ultrasound. The diagnosis is made by full thickness 
incisional biopsy of the skin and subcutaneous tissues down 
to the muscle surface. Early in the disease course, edema 
and infiltration with lymphocytes, plasma cells, histiocytes, 
and eosinophils of the deep fascia and lower subcutis is a 
typical feature on biopsy. The majority of patients have eo-
sinophil infiltrates; however, this finding may be absent. As 
the disease progresses, the inflammatory infiltrates disappear 
and the fascia and subcutis become thickened and sclerotic. 
Thickening and inflammation can also be seen in or around 
muscles. Perivascular infiltrates of lymphocytes are almost 
always present. Initial treatment for EF consists of systemic 
glucocorticoids, usually at a dose of 1 mg/kg/day with dose 
reduction based on skin softening which can take weeks to 
months. Higher doses of glucocorticoids should be used if 
EF signs and symptoms do not improve and eosinophilia 
persists. No randomized trials have evaluated therapy for EF, 
but several different immunosuppressants (methotrexate, my-
cophenolate, azathioprine, infliximab, rituximab, hydroxy-
chloroquine) have been used in steroid resistant patients or 
patients who relapse.11
Due to the positive Lyme serology in our patient, gran-
ulomatous fasciitis caused by Lyme disease was consid-
ered. However, we were unable to demonstrate spirochete or 
Borrelia DNA in the tissue. Upon review of the literature, 
there have been no case reports of granulomatous fasciitis 
associated with Lyme disease. However, a causal relationship 
of Borrelia burgdorferi infection with eosinophilic fasciitis 
(EF) was suggested in 1987.12 Since then, a handful of cases 
have been reported with the association due to findings of EF 
on biopsy with serologic tests positive for Lyme (some using 
ELISA alone, immunoblot alone or both). These cases were 
unable to demonstrate Borrelia organisms in the biopsies. 
The timeline of EF onset in these case reports occurred any-
where from a few months to a few years after tick bite with-
out typical Lyme symptoms in most cases.13 In 1996, Granter 
et al13 identified four cases of diffuse fasciitis associated with 
peripheral eosinophilia in which spirochetal organisms were 
identified on biopsy. In one patient, multiple organisms were 
seen using a modified Dieterle silver stain, two patients had 
only a single unequivocal organism detected via silver stain, 
while the fourth patient had a negative silver stain, but or-
ganisms were identified using rabbit polyclonal antibodies 
against B burgdorferi. One patient with detection by silver 
stain was found to have no clinical or serological evidence 
of Lyme disease. They proposed that these results indicate 
that some cases of EF are an expression of Lyme disease and 
that borrelial fasciitis should describe these lesions. There 
has been another case reported by Hashimoto et al14 in which 
a patient had onset of EF 2 years after a tick bite with positive 
ELISA for B burgdorferi, negative Warthin- Starry stain, but 
detection of B burgdorferi flagellin DNA in the skin sample 
using PCR.
Although eosinophilic fasciitis is known to be part of deep 
morphea spectrum, this is the first report of coexistence of 
granulomatous fasciitis and morphea profunda. Morphea is a 
type of localized scleroderma in which excessive collagen is 
deposited in the dermis, subcutaneous tissue, or both. It lacks 
the internal organ involvement that can be seen with systemic 
sclerosis. Deep morphea, or morphea profunda, is one of the 
more rare clinical variants of morphea and can extend into the 
fascia and muscle.15 Morphea has been associated with both 
eosinophilic fasciitis and Lyme disease.16,17 The pathogenesis 
of morphea is poorly understood, but environmental factors 
such as radiation, trauma, or infection have been proposed as a 
trigger. B. burgdorferi has been implicated in the causation of 
morphea; however, the role it plays remains controversial.16 It 
is thought that the inflammatory and immune process elicited 
by the presence of the spirochete within the patient’s tissues 
plays a role in the onset of morphea. In European series, an-
tibodies to B. burgdorferi were detected in one- third to one- 
half of the morphea patients; however, serological studies in 
the United States have reported negative results. Direct detec-
tion by culture of the affected skin has had limited success in 
Europe. PCR studies have been positive in about one- seventh 
of cases in Europe and Asia, but consistently negative in the 
United States.16 Thus, B. burgdorferi is not accepted as a 
causative agent in morphea. Of interest to our case, there is 
also an ongoing discussion as to whether EF is a variant of 
1416 |   CHRISTENSEN ET al.
morphea. There have been cases in which morphea and EF co-
exist; however, the combination is considered to be rare.17 The 
first association was reported by Lakhanpal in which 15 of 
52 patients with EF also had morphea.18 Several case reports 
with features of both diseases have been presented since then 
with suggestion that these diseases are a more closely related 
continuum rather than separate diseases.17
3 |  CONCLUSION
In our patient’s case, despite findings of limb edema with 
mild peripheral eosinophilia, the biopsy lacked evidence for 
eosinophilic fasciitis and instead revealed granulomatous in-
flammation of the fascia and vasculitis. A skin specimen was 
not available at the time of granulomatous fasciitis diagno-
sis to assess for morphea, and there were no dermatological 
manifestations at that time. It was not until prednisone taper-
ing that the patient developed skin changes consistent with 
morphea profunda on the arm. During initial workup, the 
patient had positive Lyme serology via ELISA and immu-
noblot. Microbial testing of the fascia and muscle tissue was 
negative for Lyme disease; however, testing was performed 
after the patient had been on doxycycline for 3 weeks, which 
could have decreased the yield. Although we cannot claim 
causality, it is possible that the immune response against the 
Borrelia spirochete triggered an autoimmune response and 
the patient’s current manifestations. It is also important to 
have in mind the diagnosis of Lyme disease as a possible trig-
ger in autoimmune connective tissue disorders. Skin trauma 
has been involved in morphea profunda, which could be 
another environmental trigger for this patient to develop an-
other manifestation in the spectrum of morphea profunda/eo-
sinophilic fasciitis. Although eosinophilic fasciitis is known 
to be part of the deep morphea spectrum, this first report of 
the coexistence of granulomatous fasciitis and morphea pro-
funda suggests that granulomatous fasciitis may also be a part 
of the spectrum of deep morphea.
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